Cited by 506Genomics and Chromatin DynamicsRNA Research and SplicingGenomics and Phylogenetic Studies

Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes

Open access
Kimura, Kouichi, Wakamatsu, Ai, Suzuki, Yutaka, Ota, Toshio, Nishikawa, Tetsuo, Yamashita, Riu, Yamamoto, Jun-ichi, Sekine, Mitsuo +24 more·2006·Genome Research

Abstract

By analyzing 1,780,295 5′-end sequences of human full-length cDNAs derived from 164 kinds of oligo-cap cDNA libraries, we identified 269,774 independent positions of transcriptional start sites (TSSs) for 14,628 human RefSeq genes. These TSSs were clustered into 30,964 clusters that were separated from each other by more than 500 bp and thus are very likely to constitute mutually distinct alternative promoters. To our surprise, at least 7674 (52%) human RefSeq genes were subject to regulation by putative alternative promoters (PAPs). On average, there were 3.1 PAPs per gene, with the composition of one CpG-island-containing promoter per 2.6 CpG-less promoters. In 17% of the PAP-containing loci, tissue-specific use of the PAPs was observed. The richest tissue sources of the tissue-specific PAPs were testis and brain. It was also intriguing that the PAP-containing promoters were enriched in the genes encoding signal transduction-related proteins and were rarer in the genes encoding extracellular proteins, possibly reflecting the varied functional requirement for and the restricted expression of those categories of genes, respectively. The patterns of the first exons were highly diverse as well. On average, there were 7.7 different splicing types of first exons per locus partly produced by the PAPs, suggesting that a wide variety of transcripts can be achieved by this mechanism. Our findings suggest that use of alternate promoters and consequent alternative use of first exons should play a pivotal role in generating the complexity required for the highly elaborated molecular systems in humans.

Integrity signals

Registry

Crossref · 10.1101/gr.4039406

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kimura, K., Wakamatsu, A., Suzuki, Y., Ota, T., Nishikawa, T., Yamashita, R., Yamamoto, J.-I., Sekine, M., Tsuritani, K., Wakaguri, H., Ishii, S., Sugiyama, T., Saito, K., Isono, Y., Irie, R., Kushida, N., Yoneyama, T., Otsuka, R., Kanda, K., Yokoi, T., Kondo, H., Wagatsuma, M., Murakawa, K., Ishida, S., Ishibashi, T., Takahashi-Fujii, A., Tanase, T., Nagai, K., Kikuchi, H., Nakai, K., Isogai, T., & Sugano, S.
Affiliations
  • Hitachi (Japan) (JP)
  • The University of Tokyo (JP)
  • Institute of Medical Science, The University of Tokyo (JP)
  • National Institute of Technology and Evaluation (JP)
  • Tokyo University of Technology (JP)
  • Takara Shuzo Co., Ltd. (Japan) (JP)
Venue
Genome Research
Published
2005-12-12
Volume
16
Issue
1
Pages
55-65
ISSN
1088-9051 (ISSN-L)
OpenAlex
W2138197117
Cited by
506
References
3
Citations by year
2026: 5 · 2025: 18 · 2024: 14 · 2023: 11 · 2022: 32 · 2021: 29 · 2020: 28 · 2019: 15 · 2018: 15 · 2017: 19 · 2016: 21 · 2015: 23 · 2014: 14 · 2013: 24 · 2012: 28
Type
posted content
Language
en
Open access
Locations
  • Genome Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Economy, Trade and Industry
  • National Institutes of Health (Z99 DA999999)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
alternative promoters, transcription start sites, human genes, full-length cDNA, CpG islands, tissue-specific promoters, alternative splicing, signal transduction genes, extracellular proteins, transcriptome complexity
MeSH terms
Base Sequence, Exons, Multigene Family, Humans, Molecular Sequence Data, Organ Specificity, Promoter Regions, Genetic, Transcription, Genetic, Signal Transduction, Gene Library, CpG Islands, Quantitative Trait Loci

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review